Journal article
301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
Annals of Oncology, Vol.31(Supp. 6), pp.S1359-S1360
2020
Abstract
We aimed to assess the role of genomic HLA-I/II homozygosity in the overall survival benefit in patients with unresectable locally advanced, metastatic non-small lung cancer treated by single agent PD1/PDL1 inhibitors...
Details
- Title
- 301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
- Authors/Creators
- A. Abed (Author/Creator) - Fiona Stanley HospitalL. Calapre (Author/Creator) - Edith Cowan UniversityJ. Lo (Author/Creator) - Edith Cowan UniversityS. Correia (Author/Creator) - Fiona Stanley HospitalS. Bowyer (Author/Creator) - Sir Charles Gairdner HospitalA. Chopra (Author/Creator) - Murdoch UniversityM. Watson (Author/Creator) - Murdoch UniversityM. Khattak (Author/Creator) - Fiona Stanley HospitalM. Millward (Author/Creator) - Sir Charles Gairdner HospitalE. Gray (Author/Creator) - Edith Cowan University
- Publication Details
- Annals of Oncology, Vol.31(Supp. 6), pp.S1359-S1360
- Publisher
- Elsevier Inc.
- Identifiers
- 991005541590507891
- Copyright
- © 2020 European Society for Medical Oncology.
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
Metrics
63 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 6 Social Sciences
- 6.294 Operations Research & Management Science
- 6.294.1808 Distributed Simulation
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine